Dec 2, 2025tirzepatide (zepbound brand) is a once-weekly injection used for weight loss, weight management, and weight-related conditions, including obstructive sleep apnea (osa). Jan 19, 2026tirzepatide, marketed as mounjaro and recently also as zepbound specifically for weight management, was approved for type 2 diabetes in 2022 and for weight management in 2023. Jan 1, 2026tirzepatide injection is used to treat type 2 diabetes.
Dec 27, 2024find patient medical information for zepbound (tirzepatide) on webmd including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Jan 13, 2025tirzepatide is a prescription medication indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Jun 4, 2022tirzepatide is a once-weekly subcutaneous injectable peptide (approved by the food and drug administration [fda] for type 2 diabetes) engineered from the native gip sequence, with agonist.
Aug 9, 2024learn everything about tirzepatide:
'/><text x='50%' y='52%' font-family='Arial,Helvetica,sans-serif' font-size='44' fill='white' text-anchor='middle' dominant-baseline='middle'>Jule</text></svg>)
